Viveve Medical (NASDAQ:VIVE – Get Free Report) is expected to release its results on Friday, November 13th. Analysts expect Viveve Medical to announce earnings of ($0.51) per share and revenue of $1.33 million for the quarter.
Viveve Medical Stock Performance
Shares of NASDAQ:VIVE opened at $0.00 on Thursday. Viveve Medical has a 12 month low of $0.00 and a 12 month high of $0.00.
Viveve Medical Company Profile
Viveve Medical, Inc. was a women’s health medical-device company focused on developing and commercializing non-surgical treatments for gynecological conditions. Its principal product was the Viveve System, which used cryogen-cooled monopolar radiofrequency energy to heat tissue and stimulate collagen remodeling. The Viveve System was marketed for procedures addressing vaginal laxity and related concerns in women’s intimate health. The company pursued commercialization through direct sales and distribution relationships in the United States and international markets, although product availability and regulatory status varied by geography.
Read More
- Five stocks we like better than Viveve Medical
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.
